Atria Wealth Solutions’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,825
Closed -$213K 1807
2025
Q1
$213K Buy
+6,825
New +$223K ﹤0.01% 1680
2024
Q3
Sell
-10,119
Closed -$314K 2028
2024
Q2
$314K Buy
10,119
+93
+0.9% +$2.77K ﹤0.01% 1474
2024
Q1
$298K Buy
+10,026
New +$284K ﹤0.01% 1561

Other funds holding QLTY

Atria Wealth Solutions's QLTY Position: Q2 2025 in Review

Atria Wealth Solutions sold out of GMO US Quality ETF (QLTY) in Q2 2025, closing a stake of 6,825 shares — an estimated $213K sold.

Atria Wealth Solutions first reported a position in QLTY in Q1 2024 and held it in 3 quarters. The position peaked at $314K in Q2 2024. 111 funds tracked by Wall St. Rank hold QLTY as of Q2 2025.

  • Atria Wealth Solutions reported no remaining GMO US Quality ETF position as of Q2 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 6,825 GMO US Quality ETF shares in Q2 2025, an estimated $213K.
  • Atria Wealth Solutions first reported a position in GMO US Quality ETF in Q1 2024 and held it in 3 quarters.
  • Atria Wealth Solutions's GMO US Quality ETF position peaked at $314K in Q2 2024.
  • 111 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.